The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris: Supported by the EDF/EADV/IPC
Open accessAbstract
Of the 131 studies on monotherapy or combination therapy assessed, 56 studies on the different forms of phototherapy fulfilled the criteria for inclusion in the guidelines. Approximately three-quarters of all patients treated with phototherapy attained at least a PASI 75 response after 4 to 6 weeks, and clearance was frequently achieved (levels of evidence 2 and 3). Phototherapy represents a safe and very effective treatment option for moderate to severe forms of psoriasis vulgaris. The onset of clinical effects occurs within 2 weeks. Of the unwanted side effects, UV erythema from overexposure is by far the most common and is observed frequently. With repeated or long-term use, the consequences of high, cumulative UV doses (such as premature aging of the skin) must be taken into consideration. In addition, carcinogenic risk is associated with oral PUVA and is probable for local PUVA and UVB. The practicability of the therapy is limited by spatial, financial, human, and time constraints on the part of the physician, as well as by the amount of time required by the patient. From the perspective of the cost-bearing institution, phototherapy has a good cost-benefit ratio. However, the potentially significant costs for, and time required of, the patient must be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Psoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet Light
Parrish, J. A., Fitzpatrick, T. B., Tanenbaum, L., & Pathak, M. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197412052912301 · Cited by 1,376
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Self-citationMacrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Self-citationCargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069
Self-citationReich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045
Self-citationKrueger, G. G., Koo, J. Y. M., Lebwohl, M., Menter, A., Stern, R. S., & Rolstad, T. (2001) · PubMed · Cited by 969
Self-citationEfficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Self-citationGupta, & Gupta (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02511.x · Cited by 864
Hongbo, Y., Thomas, C. L., Harrison, M. A., Sam Salek, M., & Finlay, A. Y. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23621.x · Cited by 854
Kabat-Zinn, J., Wheeler, E., Light, T., Skillings, A., Scharf, M. J., Cropley, T. G., Hosmer, D., & Bernhard, J. D. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199809000-00020 · Cited by 826
Stern, R. S., Nijsten, T., Feldman, S. R., Margolis, D. J., & Rolstad, T. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09102.x · Cited by 732
Self-citationVan den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C., Krueger, G. G., de Vlam, K., Birbara, C., Beutler, A., Guzzo, C., Zhou, B., Dooley, L. T., & Kavanaugh, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032268 · Cited by 715
Papp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693
Self-citation(2005) · PsycEXTRA Dataset · doi:10.1037/e548692006-002 · Cited by 691
Scallon, B. (1995) · Cytokine · doi:10.1006/cyto.1995.0029 · Cited by 675
Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582
Gottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
Self-citationA Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
Lebwohl, M., Tyring, S. K., Hamilton, T. K., Toth, D., Glazer, S., Tawfik, N. H., Walicke, P., Dummer, W., Wang, X., Garovoy, M. R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030002 · Cited by 570
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Boyman, O., Hefti, H. P., Conrad, C., Nickoloff, B. J., Suter, M., & Nestle, F. O. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031482 · Cited by 522
Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Self-citationElevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
ETTEHADI, P., GREAVES, M. W., WALLACH, D., ADERKA, D., & CAMP, R. D. R. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06244.x · Cited by 481
Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque Psoriasis
Heydendael, V. M. R., Spuls, P. I., Opmeer, B. C., de Borgie, C. A. J. M., Reitsma, J. B., Goldschmidt, W. F. M., Bossuyt, P. M. M., Bos, J. D., & de Rie, M. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021359 · Cited by 475
Self-citationA Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
Katz, J. A., Antoni, C., Keenan, G. F., Smith, D. E., Jacobs, S. J., & Lichtenstein, G. R. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30186.x · Cited by 463
Cyclosporine for Plaque-Type Psoriasis: Results of a Multidose, Double-Blind Trial
Ellis, C. N., Fradin, M. S., Messana, J. M., Brown, M. D., Siegel, M. T., Hartley, A. H., Rocher, L. L., Wheeler, S., Hamilton, T. A., Parish, T. G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240501 · Cited by 429
Psychiatric morbidity in dermatological outpatients: an issue to be recognized
Picardi, A., Abeni, D., Melchi, C. F., Puddu, P., & Pasquini, P. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03831.x · Cited by 413
Van Ede, A. E., Laan, R. F. J. M., Rood, M. J., Huizinga, T. W. J., Van De Laar, M. A. F. J., Denderen, C. J. V., Westgeest, T. A. A., Romme, T. C., De Rooij, D.-J. R. A. M., Jacobs, M. J. M., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1515::aid-art273>3.0.co;2-7 · Cited by 401
Current severe psoriasis and the Rule of Tens
Finlay, A. Y. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06502.x · Cited by 394
Efalizumab for Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial
Gordon, K. B., Papp, K. A., Hamilton, T. K., Walicke, P. A., Dummer, W., Li, N., Bresnahan, B. W., Menter, A., & for the Efalizumab Study Group (2003) · JAMA · doi:10.1001/jama.290.23.3073 · Cited by 391
Self-citationIncreased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients
Mallbris, L., Akre, O., Granath, F., Yin, L., Lindelöf, B., Ekbom, A., & Ståhle-Bäckdahl, M. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000020447.59150.f9 · Cited by 390
Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study
Paul, C. F., HO, V. C., McGeown, C., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12040.x · Cited by 388
Methotrexate and histologic hepatic abnormalities: A meta-analysis
Whiting-O'Keefe, Q. E., Fye, K. H., & Sack, K. D. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80060-9 · Cited by 358
Shea, B., Swinden, M. V., Tanjong Ghogomu, E., Ortiz, Z., Katchamart, W., Rader, T., Bombardier, C., Wells, G. A., & Tugwell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000951.pub2 · Cited by 347
Incidence and Risk Factors for Psoriasis in the General Population
Huerta, C., Rivero, E., & Rodríguez, L. A. G. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1559 · Cited by 343
Krueger, G. G., Papp, K. A., Stough, D. B., Loven, K. H., Gulliver, W. P., & Ellis, C. N. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.127247 · Cited by 338
Dubertret, L., Mrowietz, U., Ranki, A., Van De Kerkhof, P. C. M., Chimenti, S., Lotti, T., Schäfer, G., & survey, E. P. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07405.x · Cited by 329
Self-citationLong-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis
Tyring, S., Gordon, K. B., Poulin, Y., Langley, R. G., Gottlieb, A. B., Dunn, M., & Jahreis, A. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.6.719 · Cited by 324
Psychiatric morbidity in dermatological outpatients: an issue to be recognized
Aslam, R., Qadir, A., & Asad, F. (2016) · Journal of Pakistan Association of Dermatologists · doi:10.66344/jpad.v17i4.707 · Cited by 315
Antipsoriatic effect of fumaric acid derivatives
Altmeyer, P. J., Mattlies, U., Pawlak, F., Hoffmann, K., Frosch, P. J., Ruppert, P., Wassilew, S. W., Horn, T., Kreysel, H. W., Lutz, G., et al. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70121-0 · Cited by 300
The contribution of perceptions of stigmatisation to disability in patients with psoriasis
Richards, H. L., Fortune, D. G., Griffiths, C. E. M., & Main, C. J. (2001) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00210-5 · Cited by 298
Self-citationPartsch, G., Steiner, G. E., Leeb, B. F., Dunky, A., Bröll, H., & Smolen, J. S. (1997) · PubMed · Cited by 297
Infections and anti–tumor necrosis factor α therapy
Ellerin, T., Rubin, R. H., & Weinblatt, M. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11301 · Cited by 284
NEVITT, G. J., & HUTCHINSON, P. E. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1035.x · Cited by 281
Smith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., Chandler, D., Finlay, A. Y., Grifitths, C. E. M., Jackson, K., McHugh, N. J., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06893.x · Cited by 275
Self-citationAugustin, M., Krüger, K., Radtke, M. A., Schwippl, I., & Reich, K. (2008) · Dermatology · doi:10.1159/000119415 · Cited by 271
Self-citationMethotrexate for psoriasis. A new therapeutic schedule
Weinstein, G. D. (1971) · Archives of Dermatology · doi:10.1001/archderm.103.1.33 · Cited by 268
Marcil, I., & Stern, R. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06179-7 · Cited by 258
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91387-5 · Cited by 257
Patients with psoriasis and their compliance with medication☆, ☆☆, ★, ★★
RICHARDS, H., FORTUNE, D., OSULLIVAN, T., MAIN, C., & GRIFFITHS, C. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70301-4 · Cited by 255
Self-citationA cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy
Fortune, D. G., Richards, H. L., Kirby, B., Bowcock, S., Main, C. J., & Griffiths, C. E. M. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04622.x · Cited by 255
Self-citationAn Italian Study on Psoriasis and Depression
Esposito, M., Saraceno, R., Giunta, A., Maccarone, M., & Chimenti, S. (2006) · Dermatology · doi:10.1159/000090652 · Cited by 249
Self-citationPsychological Distress Impairs Clearance of Psoriasis in Patients Treated With Photochemotherapy
Fortune, D. G., Richards, H. L., Kirby, B., McElhone, K., Markham, T., Rogers, S., Main, C. J., & Griffiths, C. E. M. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.6.752 · Cited by 245
Self-citationPsychologic Factors in Psoriasis: Consequences, Mechanisms, and Interventions
Fortune, D. G., Richards, H. L., & Griffiths, C. E. M. (2005) · Dermatologic Clinics · doi:10.1016/j.det.2005.05.022 · Cited by 244
Self-citationEtanercept and efalizumab for the treatment of psoriasis: a systematic review
Woolacott, N., Hawkins, N., Mason, A., Kainth, A., Khadjesari, Z., Bravo Vergel, Y., Misso, K., Light, K., Chalmers, R., Sculpher, M., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10460 · Cited by 241
Coven, T. R. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.12.1514 · Cited by 232
Smeets, T. J. M., Kraan, M. C., van Loon, M. E., & Tak, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11098 · Cited by 224
Menter, A. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.1.31 · Cited by 211
Self-citationORAL 8-METHOXYPSORALEN PHOTOCHEMOTHERAPY OF PSORIASIS
Henseler, T., Hönigsmann, H., Wolff, K., & Christophers, E. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92137-1 · Cited by 210
Self-citationEvers, A. W. M., Lu, Y., Duller, P., van der Valk, P. G. M., Kraaimaat, F. W., & van de Kerkhof, P. C. M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06565.x · Cited by 203
Self-citationSafety of Tumour Necrosis Factor-?? Antagonists
Khanna, D., McMahon, M., & Furst, D. E. (2004) · Drug Safety · doi:10.2165/00002018-200427050-00003 · Cited by 202
308-nm Excimer Laser for the Treatment of Psoriasis: A Dose-Response Study
Asawanonda, P., Anderson, R. R., Chang, Y., & Taylor, C. R. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.5.619 · Cited by 202
Gottlieb, A., Krueger, J. G., Bright, R., Ling, M., Lebwohl, M., Kang, S., Feldman, S., Spellman, M., Wittkowski, K., Ochs, H. D., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90214-7 · Cited by 201
Matsuno, H., Yudoh, K., Katayama, R., Nakazawa, F., Uzuki, M., Sawai, T., Yonezawa, T., Saeki, Y., Panayi, G. S., Pitzalis, C., et al. (2002) · Rheumatology · doi:10.1093/rheumatology/41.3.329 · Cited by 200
Lundberg, L., Johannesson, M., Silverdahl, M., Hermansson, C., & Lindberg, M. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03207.x · Cited by 199
Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study
Mrowietz, Christophers, Altmeyer, & STUDY, T. P. I. T. G. M. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02124.x · Cited by 197
Biological therapies in the systemic management of psoriasis: International Consensus Conference
Sterry, W., Barker, J., Boehncke, W.-H., Bos, J. D., Chimenti, S., Christophers, E., De La Brassinne, M., Ferrandiz, C., Griffiths, C., Katsambas, A., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06070.x · Cited by 194
Self-citationA randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis
Gordon, P. M., Diffey, B. L., Matthews, J. N. S., & Farr, P. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70008-3 · Cited by 191
Vardy, D., Besser, A., Amir, M., Gesthalter, B., Biton, A., & Buskila, D. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04899.x · Cited by 190
308 nm UVB excimer laser for psoriasis
Bonis, B., Kemény, L., Dobozy, A., Bor, Z., Szabó, G., & Ignacz, F. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63945-1 · Cited by 186
Di Sabatino, A. (2004) · Gut · doi:10.1136/gut.53.1.70 · Cited by 186
Smoking and the Risk of Psoriasis in Women: Nurses’ Health Study II
Setty, A. R., Curhan, G., & Choi, H. K. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.020 · Cited by 185
Psoriasis and sex: a study of moderately to severely affected patients
Gupta, M. A., & Gupta, A. K. (1997) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1997.00032.x · Cited by 183
Efficacy of the 308-nm excimer laser for treatment of psoriasis: Results of a multicenter study
Feldman, S. R., Mellen, B. G., Housman, T. S., Fitzpatrick, R. E., Geronemus, R. G., Friedman, P. M., Vasily, D. B., & Morison, W. L. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120454 · Cited by 180
Hönigsmann, H. (2001) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2001.00828.x · Cited by 176
Self-citationAcitretin plus UVB therapy for psoriasis
Lowe, N. J., Prystowsky, J. H., Bourget, T., Edelstein, J., Nychay, S., & Armstrong, R. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70089-k · Cited by 167
Assessment of depression in subjects with psoriasis vulgaris and lichen planus
Akay, A., Pekcanlar, A., Bozdag, K., Altintas, L., & Karaman, A. (2002) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2002.00467.x · Cited by 164
Reitamo, S., Spuls, P. I., Sassolas, B., Lahfa, M., Claudy, A., Griffiths, C. E. M., & FOR THE SIROLIMUS EUROPEAN PSORIASIS STUDY GROUP (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04376.x · Cited by 161
Self-citationCiclosporin in psoriasis clinical practice: an international consensus statement
Griffiths, C. E. M., Dubertret, L., Ellis, C. N., Finlay, A. Y., Finzi, A. F., HO, V. C., Johnston, A. E., Katsambas, A. D., Lison, A.-E., Naeyaert, J. M., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.0366-077x.2004.05949.x · Cited by 152
Self-citationRelapse, rebound, and psoriasis adverse events: An advisory group report
Carey, W. D., Glazer, S. D., Gottlieb, A. B., Lebwohl, M., Leonardi, C. L., Menter, A., Papp, K. A., Rundle, A. C., & Toth, D. P. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.029 · Cited by 149
Self-citationSaurat, J. ‐., Geiger, J.-M., Amblard, P., Béani, J.-C., Boulanger, A., Claudy, A., Frenk, E., Guilhou, J. J., Grosshans, E., Mérot, Y., et al. (2009) · Dermatologica · doi:10.1159/000248567 · Cited by 144
Gisondi, P., Giglio, M. D., Cotena, C., & Girolomoni, G. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08564.x · Cited by 143
Self-citationTreatment of Psoriasis with Folic Acid Antagonists
Edmundson, W. F. (1958) · Archives of Dermatology · doi:10.1001/archderm.1958.01560080060010 · Cited by 143
Dubertret, L., Sterry, W., Bos, J. D., Chimenti, S., Shumack, S. P., Larsen, C. G., Shear, N. H., Papp, K. A., & CLEAR Multinational Study Group (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07344.x · Cited by 143
Self-citationYano, K., Kadoya, K., Kajiya, K., Hong, Y.-K., & Detmar, M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06368.x · Cited by 138
Reich, K., Nestle, F. O., Papp, K. A., Ortonne, J. ‐., Wu, Y., BALA, M. M., Evans, R., Guzzo, C. A., Li, S., Dooley, L. T., et al. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07237.x · Cited by 138
Self-citationFeldman, S. R., Gordon, K. B., BALA, M. M., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Patel, K. R., Menter, A., & Gottlieb, A. B. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06510.x · Cited by 133
Self-citationHigh-dose 308-nm excimer laser for the treatment of psoriasis
Trehan, M., & Taylor, C. R. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120538 · Cited by 129
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
Nast, A., Kopp, I., Augustin, M., Banditt, K., Boehncke, W., Follmann, M., Friedrich, M., Huber, M., Kahl, C. R., Klaus, J., et al. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0744-y · Cited by 129
Self-citationLong-term Safety of Cyclosporine in the Treatment of Psoriasis
Grossman, R. (1996) · Archives of Dermatology · doi:10.1001/archderm.132.6.623 · Cited by 128
Infections Associated with Tumor Necrosis Factor‐α Antagonists
Rychly, D. J., & DiPiro, J. T. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.9.1181 · Cited by 127
Naldi, L., Peli, L., & Parazzini, F. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.12.1479 · Cited by 127
Self-citationOrtiz, Z., Shea, B., Suarez-Almazor, M. E., Moher, D., Wells, G. A., & Tugwell, P. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000951 · Cited by 126
Acitretin improves psoriasis in a dose-dependent fashion
Goldfarb, M. T., Ellis, C. N., Gupta, A. K., Tincoff, T., Hamilton, T. A., & Voorhees, J. J. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70086-9 · Cited by 125
The mechanisms of action of cyclosporin A in the treatment of psoriasis
Wong, R. L., Winslow, C. M., & Cooper, K. D. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90061-o · Cited by 124
Richards, H. L., Fortune, D. G., Weidmann, A. K., Sweeney, S. K. T., & Griffiths, C. E. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06221.x · Cited by 123
Self-citationAlterations of the mucosal immune system in inflammatory bowel disease
MacDermoit, R. P. (1996) · Journal of Gastroenterology · doi:10.1007/bf02358624 · Cited by 121
Fortune, D. G., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2004) · British Journal of Clinical Psychology · doi:10.1348/014466504772812977 · Cited by 117
Self-citationYoung, H. S., Summers, A., Read, I., Fairhurst, D. A., Plant, D., Campalani, E., Smith, C. H., Barker, J. N. W. N., Detmar, M. J., Brenchley, P. E., et al. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700096 · Cited by 117
Self-citationWahl, A. K., Loge, J. H., Wiklund, I. E., & Hanestad, B. R. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107501 · Cited by 114
Markham, T., Rogers, S., & Collins, P. M. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.3.325 · Cited by 114
S3‐Leitlinie zur Therapie der Psoriasis vulgaris
Nast, A., Kopp, I., Augustin, M., Banditt, K., Boehncke, W., Follmann, M., Friedrich, M., Huber, M., Kahl, C. R., Klaus, J., et al. (2006) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2006.06172.x · Cited by 113
Self-citationReich, K., Mößner, R., Neumann, C. R., König, I. R., Westphal, G., & Ziegler, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01642.x · Cited by 113
Self-citationZACHARIAE, H., Heickendorff, L., & SØGAARD, H. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.03959.x · Cited by 111
Combined methotrexate-PUVA therapy in the treatment of psoriasis
Morison, W. L., Momtaz-T, K., Parrish, J. A., & Fitzpatrick, T. B. (1982) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(82)70005-2 · Cited by 108
COMPARISON OF PHOTOCHEMOTHERAPY AND DITHRANOL IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS
Rogers, S., MARKS, J. M., Shuster, S., Briffa, D. V., WARIN, A. P., & Greaves, M. W. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90820-1 · Cited by 107
Gupta, M. A., Gupta, A. K., & Watteel, G. N. (1998) · PubMed · Cited by 104
Leary, M. R., Rapp, S. R., Herbst, K. C., Exum, M. L., & Feldman, S. R. (1998) · Health Psychology · doi:10.1037//0278-6133.17.6.530 · Cited by 104
Tazarotene plus UVB phototherapy in the treatment of psoriasis
Koo, J. Y. M., Lowe, N. J., Lew‐Kaya, D. A., Vasilopoulos, A. I., Lue, J. C., Sefton, J., & Gibson, J. R. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107940 · Cited by 102
Asawanonda, P., & Nateetongrungsak, Y. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.01.004 · Cited by 93
Reich, K., & Mrowietz, U. (2007) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2007.06343.x · Cited by 93
Self-citationFortune, D. G., Richards, H. L., Kirby, B., McElhone, K., Main, C. J., & Griffiths, C. E. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06222.x · Cited by 92
Self-citationKoellner, K., Wimmershoff, M. B., Hintz, C., Landthaler, M., & Hohenleutner, U. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06533.x · Cited by 91
Combined methotrexate-ultraviolet B therapy in the treatment of psoriasis
Paul, B. S., Momtaz-T, K., Stern, R. S., Arndt, K. A., & Parrish, J. A. (1982) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(82)70157-4 · Cited by 91
Efalizumab: a review of events reported during clinical trials and side effects
Scheinfeld, N. S. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.2.197 · Cited by 91
Murray, H. E., Anhalt, A. W., Lessard, R., Schachter, R. K., Ross, J. M., Stewart, W. D., & Geiger, J. M. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70091-f · Cited by 88
Lauharanta, J., & Geiger, J. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01406.x · Cited by 87
Medium-dose 308-nm excimer laser for the treatment of psoriasis
Trehan, M., & Taylor, C. R. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.125075 · Cited by 82
Gottlieb, A. B., Gordon, K. B., Lebwohl, M., Caro, I., Walicke, P. A., Li, N., & Leonardi, C. L. (2004) · PubMed · Cited by 79
Self-citationNewman, M. (1989) · Archives of Dermatology · doi:10.1001/archderm.125.9.1218 · Cited by 79
Divergent Beliefs About Psoriasis Are Associated with Increased Psychological Distress
Richards, H. L., Fortune, D. G., Chong, S. L. P., Mason, D., Sweeney, S. K. T., Main, C. J., & Griffiths, C. E. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22703.x · Cited by 75
Self-citationStern, R. S. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680030067008 · Cited by 75
Isotretinoin vs Etretinate Therapy in Generalized Pustular and Chronic Psoriasis
Moy, R. L. (1985) · Archives of Dermatology · doi:10.1001/archderm.1985.01660100077019 · Cited by 69
The Role of Liver Biopsies in Psoriatic Patients Receiving Long-term Methotrexate Treatment
Newman, M. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670210056007 · Cited by 68
Maurice, P. D. L., Maddox, A. J., Green, C. A., Tatnall, F. M., Schofield, J., & Stott, D. J. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06459.x · Cited by 67
Tar Gel-Phototherapy for Psoriasis
Frost, P. (1979) · Archives of Dermatology · doi:10.1001/archderm.1979.04010070016013 · Cited by 64
Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service
Cameron, H., Yule, S., Moseley, H., Dawe, R. S., & Ferguson, J. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04860.x · Cited by 63
Self-citationTumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis
Roberts, L. J., & McColl, G. (2004) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2004.00710.x · Cited by 60
Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis
Grundmann-Kollmann, M., Ludwig, R. J., Zollner, T. M., Ochsendorf, F. R., Thaçi, D., Boehncke, W., Krutmann, J., Kaufmann, R., & Podda, M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)00792-8 · Cited by 60
Effectiveness of cyclosporine treatment in severe psoriasis: A clinical and immunologic study
Finzi, A. F., Mozzanica, N., Cattaneo, A., Chiappino, G., & Pigatto, P. D. M. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70154-7 · Cited by 59
Cooper, Herd, Priestley, & Hunter, A. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00589.x · Cited by 58
Parker, S., Coburn, P. R., AWRENCE, C. L., MARKS, J. M., & Shuster, S. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb07470.x · Cited by 55
Litjens, N. H. R., Nibbering, P. H., Barrois, A., Zomerdijk, T. P. L., Oudenrijn, A. C. V. D., Noz, K. C., Rademaker, M., van der Meide, P. H., van Dissel, J. T., & Thio, B. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05153.x · Cited by 55
Ortonne, J. ‐., Khemis, A., Koo, J., & Choi, J. W. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2005.01247.x · Cited by 52
Self-citationEfficacy of Acitretin and Commercial Tanning Bed Therapy for Psoriasis
Carlin, C. S., Callis, K. P., & Krueger, G. G. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.4.436 · Cited by 51
Leenutaphong, V., Nimkulrat, P., & Sudtim, S. (2000) · Photodermatology Photoimmunology & Photomedicine · doi:10.1034/j.1600-0781.2000.160502.x · Cited by 50
Cassano, N., Loconsole, F., Galluccio, A. G., Miracapillo, A., Pezza, M., & Vena, G. A. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/205873920601900123 · Cited by 49
Gollnick, H. P. M., & Dümmler, U. (1997) · Clinics in Dermatology · doi:10.1016/s0738-081x(97)00013-8 · Cited by 44
Spuls, P. I., Tuut, M. K., van Everdingen, J. J. E., & de Rie, M. A. (2004) · PubMed · Cited by 38
Self-citationKoek, M. B. G., Buskens, E., Bruijnzeel-Koomen, C. A. F. M., & Sigurdsson, V. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07136.x · Cited by 37
Nast, A., Reytan, N., Rosumeck, S., ERDMANN, R., & Rzany, B. (2008) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.02841.x · Cited by 36
Self-citationCombination Therapy for Psoriasis
Hanke, C. W. (1979) · Archives of Dermatology · doi:10.1001/archderm.1979.04010090024017 · Cited by 34
Nast, A., Spuls, P. I., Ormerod, A., Reytan, N., Saiag, P., Smith, C. H., & Rzany, B. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03166.x · Cited by 32
Self-citationTorras, H., Aliaga, A., López-Estebaranz, J. L., Hernández‐Aguado, I., Gardeazábal, J., Quintanilla, E., & Mascaró, J. M. (2004) · Journal of Dermatological Treatment · doi:10.1080/09546630410023322 · Cited by 32
A reappraisal of the use of 5‐methoxypsoralen in the therapy of psoriasis
Calzavara‐Pinton, P., Ortel, B. J., Carlino, A., Hönigsmann, H., & Panfilis, G. D. (1992) · Experimental Dermatology · doi:10.1111/j.1600-0625.1992.tb00071.x · Cited by 30
Self-citationNast, A., ERDMANN, R., Pathirana, D., & Rzany, B. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.00971.x · Cited by 30
Self-citationPsoralens and UV-A and UV-B Twice Weekly for the Treatment of Psoriasis
Diette, K. M. (1984) · Archives of Dermatology · doi:10.1001/archderm.1984.01650450051017 · Cited by 29
Khurshid, K., Haroon, T. S., Hussain, I., et al. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00913.x · Cited by 28
Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
Caca-Biljanovska, N., & V'lckova-Laskoska, M. T. (2002) · PubMed · Cited by 28
Berg, M., & Ros, A. M. (1994) · PubMed · Cited by 28
Briffa, D. V., Rogers, S., Greaves, M. W., MARKS, J. M., Shuster, S., & WARIN, A. P. (1978) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1978.tb01512.x · Cited by 27
Kirby, Buckley, & ROGERS (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02766.x · Cited by 24
Insuring Rapid and Robust Safety Assessment
Stern, R. S., & Njisten, T. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22345.x · Cited by 8
Cited by
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Definition of treatment goals for moderate to severe psoriasis: a European consensus
Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., et al. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-010-1080-1 · Cited by 898
Self-citationGriffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60125-8 · Cited by 834
Self-citationPaul, C., Cather, J., Gooderham, M., Poulin, Y., Mrowietz, U., Ferrandiz, C., Crowley, J., Hu, C., Stevens, R. M., Shah, K., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14164 · Cited by 484
Self-citationEuropean Evidence‐based (S3) Guidelines for the Treatment of Acne
Nast, A., Dréno, B., Bettoli, V., Degitz, K., Erdmann, R., Finlay, A. Y., Ganceviciene, R., Haedersdal, M., Layton, A., López‐Estebaranz, J. L., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04374.x · Cited by 426
Self-citation
Metadata
- Authors
- Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., Dubertret, L., Eberlein, B., Erdmann, R., Ferguson, J., Girolomoni, G., Gisondi, P., Giunta, A., Griffiths, C., Hönigsmann, H., Hussain, M., Jobling, R., Karvonen, S., Kemeny, L., Kopp, I., Leonardi, C., Maccarone, M., Menter, A., Mrowietz, U., Naldi, L., Nijsten, T., Ortonne, J., Orzechowski, H., Rantanen, T., Reich, K., Reytan, N., Richards, H., Thio, H., Van De Kerkhof, P., & Rzany, B.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2009-08-26
- Volume
- 23
- Issue
- s2
- Pages
- 1-70
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2069350424
- Cited by
- 703
- References
- 164
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.